Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MUFFADDAL SIRAJ MORKAS

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1235168808
CMS profile
147179
Location
HOUSTON, TX

General Payments · PY2018–2024

$5,886.01

  • Reported across 91 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$946.69

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $847.69 36
Education $99.00 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $3,907.79 7
PY2019 $27.89 2
PY2021 $25.74 2
PY2022 $224.77 7
PY2023 $753.13 36
PY2024 $946.69 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $20.31 05/09/2024 Food and Beverage Undisputed 01/23/2026 1105066546 CMS
ABBVIE INC. $27.67 09/09/2024 Food and Beverage Undisputed 01/23/2026 1105066548 CMS
ADC Therapeutics America, Inc. $26.05 02/15/2024 Food and Beverage Undisputed 01/23/2026 1121187358 CMS
Astellas Pharma US Inc $13.46 04/09/2024 Food and Beverage Undisputed 01/23/2026 1139322706 CMS
Astellas Pharma US Inc $14.00 09/26/2024 Food and Beverage Undisputed 01/23/2026 1139407711 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.36 12/12/2024 Food and Beverage Undisputed 01/23/2026 1086150081 CMS
BeiGene USA, Inc. $33.37 04/22/2024 Food and Beverage Undisputed 01/23/2026 1120852757 CMS
BeiGene USA, Inc. $21.65 08/29/2024 Food and Beverage Undisputed 01/23/2026 1120852755 CMS
Celgene Corporation $29.05 03/21/2024 Food and Beverage Undisputed 01/23/2026 1101106830 CMS
Celgene Corporation $26.78 07/18/2024 Food and Beverage Undisputed 01/23/2026 1101106834 CMS
Daiichi Sankyo Inc. $27.14 05/10/2024 Food and Beverage Undisputed 01/23/2026 1089459566 CMS
E.R. Squibb & Sons, L.L.C. $21.87 05/16/2024 Food and Beverage Undisputed 01/23/2026 1101313983 CMS
GENZYME CORPORATION $28.70 04/29/2024 Food and Beverage Undisputed 01/23/2026 1139647450 CMS
Gilead Sciences, Inc. $25.64 06/03/2024 Food and Beverage Undisputed 01/23/2026 1133802958 CMS
GlaxoSmithKline, LLC. $23.04 06/14/2024 Food and Beverage Undisputed 01/23/2026 1116350920 CMS
Immunocore Limited $32.67 08/08/2024 Food and Beverage Undisputed 01/23/2026 1103097545 CMS
Incyte Corporation $25.70 05/09/2024 Food and Beverage Undisputed 01/23/2026 1141270496 CMS
Incyte Corporation $22.37 08/26/2024 Food and Beverage Undisputed 01/23/2026 1141264659 CMS
Janssen Biotech, Inc. $21.63 02/19/2024 Food and Beverage Undisputed 01/23/2026 1078729683 CMS
Janssen Biotech, Inc. $99.00 09/10/2024 Education Undisputed 01/23/2026 1078729655 CMS
Janssen Biotech, Inc. $0.90 09/19/2024 Food and Beverage Undisputed 01/23/2026 1078729064 CMS
Janssen Biotech, Inc. $34.78 09/19/2024 Food and Beverage Undisputed 01/23/2026 1078731381 CMS
Janssen Biotech, Inc. $18.92 12/23/2024 Food and Beverage Undisputed 01/23/2026 1078731406 CMS
Karyopharm Therapeutics Inc. $19.82 02/27/2024 Food and Beverage Undisputed 01/23/2026 1145534219 CMS
Karyopharm Therapeutics Inc. $28.25 06/25/2024 Food and Beverage Undisputed 01/23/2026 1145534223 CMS
Karyopharm Therapeutics Inc. $18.30 12/03/2024 Food and Beverage Undisputed 01/23/2026 1145534227 CMS
Merck Sharp & Dohme LLC $22.74 10/28/2024 Food and Beverage Undisputed 01/23/2026 1141636435 CMS
Novartis Pharmaceuticals Corporation $24.23 04/16/2024 Food and Beverage Undisputed 01/23/2026 1087113314 CMS
Novartis Pharmaceuticals Corporation $27.98 07/22/2024 Food and Beverage Undisputed 01/23/2026 1087113296 CMS
Novartis Pharmaceuticals Corporation $25.61 10/03/2024 Food and Beverage Undisputed 01/23/2026 1087113308 CMS
Novartis Pharmaceuticals Corporation $23.42 10/10/2024 Food and Beverage Undisputed 01/23/2026 1087113306 CMS
PFIZER INC. $17.32 01/15/2024 Food and Beverage Undisputed 01/23/2026 1131280549 CMS
PFIZER INC. $17.28 03/12/2024 Food and Beverage Undisputed 01/23/2026 1131287203 CMS
PFIZER INC. $16.67 08/13/2024 Food and Beverage Undisputed 01/23/2026 1131356862 CMS
PFIZER INC. $26.94 08/22/2024 Food and Beverage Undisputed 01/23/2026 1131355750 CMS
Rigel Pharmaceuticals, Inc. $28.32 02/12/2024 Food and Beverage Undisputed 01/23/2026 1145198625 CMS
Stemline Therapeutics Inc. $30.75 12/16/2024 Food and Beverage Undisputed 01/23/2026 1142962427 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.